Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CR Shunfeng, a subsidiary of China Resources Sanjiu Medical & Pharmaceutical, is a leading Chinese pharmaceutical company specializing in the research, development, and manufacturing of external-use dermatological medications. Established in 1969 and headquartered in Foshan, the company operates one of the largest production bases for topical preparations in China. Its product portfolio includes a wide range of ointments, creams, and gels targeting conditions such as fungal infections, bacterial skin diseases, and inflammatory dermatoses. CR Shunfeng is recognized for its Shunfeng brand and maintains high-standard GMP manufacturing facilities to serve both domestic and international markets. The company is a key player in the dermatology segment of the China Resources Group's healthcare portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 华润顺峰.